Pharmaceutical stocks decline due to Trump’s 25% tariff plans.
On February 19, U.S. President Donald Trump hinted at possible pharmaceutical import duties of about 25 percent, which caused pharmaceutical stocks to plummet, with some falling as much as 10 percent. His warning that it “will be 25 percent and higher, and it’ll go very substantially higher over a year” raised concerns about the effect…